NYSE - Nasdaq Real Time Price USD

Global Medical REIT Inc. (GMRE)

Compare
8.73 +0.06 (+0.63%)
As of 11:37 AM EST. Market Open.
Loading Chart for GMRE
DELL
  • Previous Close 8.67
  • Open 8.70
  • Bid 8.72 x 1100
  • Ask 8.73 x 800
  • Day's Range 8.59 - 8.73
  • 52 Week Range 7.98 - 11.59
  • Volume 102,823
  • Avg. Volume 389,035
  • Market Cap (intraday) 602.47M
  • Beta (5Y Monthly) 1.28
  • PE Ratio (TTM) --
  • EPS (TTM) -0.02
  • Earnings Date Nov 6, 2024
  • Forward Dividend & Yield 0.84 (9.69%)
  • Ex-Dividend Date Sep 20, 2024
  • 1y Target Est 10.91

Global Medical REIT Inc. (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.

www.globalmedicalreit.com

26

Full Time Employees

December 31

Fiscal Year Ends

Recent News: GMRE

View More

Performance Overview: GMRE

Trailing total returns as of 11/15/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

GMRE
15.89%
S&P 500
23.20%

1-Year Return

GMRE
3.56%
S&P 500
30.71%

3-Year Return

GMRE
32.54%
S&P 500
25.49%

5-Year Return

GMRE
1.09%
S&P 500
89.77%

Compare To: GMRE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: GMRE

View More

Valuation Measures

Annual
As of 7/12/2024
  • Market Cap

    579.19M

  • Enterprise Value

    1.28B

  • Trailing P/E

    41.13

  • Forward P/E

    96.15

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.17

  • Price/Book (mrq)

    1.24

  • Enterprise Value/Revenue

    9.42

  • Enterprise Value/EBITDA

    14.43

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    3.23%

  • Return on Assets (ttm)

    1.71%

  • Return on Equity (ttm)

    0.72%

  • Revenue (ttm)

    136.58M

  • Net Income Avi to Common (ttm)

    -1.4M

  • Diluted EPS (ttm)

    -0.02

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    20.69M

  • Total Debt/Equity (mrq)

    112.72%

  • Levered Free Cash Flow (ttm)

    79.13M

Research Analysis: GMRE

View More

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 34.26M
Earnings 1.79M
Q4'23
Q1'24
Q2'24
Q3'24
0
10M
20M
30M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

10.00
10.91 Average
8.73 Current
12.50 High
 

Company Insights: GMRE

People Also Watch